topstockalerts
Sep 10, 1:02 AM
IQVIA Holdings announced that its wholly owned subsidiary, IQVIA Inc., priced a
$2 billion offering of senior notes due 2034. The notes will carry a 6.375% annual interest rate, with semiannual payments beginning March 15, 2027, and will mature on March 15, 2034.
Proceeds will be used to fully redeem IQVIA’s existing 5.000% senior notes due 2026, repay part of the outstanding balance under its revolving credit facility, and cover fees and expenses related to the offering. The transaction is expected to close around Sept. 23, 2026, subject to customary closing conditions.
The notes are being offered to qualified institutional buyers in the U.S. under Rule 144A and to non-U.S. investors outside the U.S. under Regulation S. IQVIA provides clinical research, commercial analytics and healthcare intelligence services to the life-sciences and healthcare industries, operating in more than 100 countries with approximately 94,000 employees.
$IQV
